Rafferty Asset Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
PAI
Rafferty Asset Management's BLUE Position: Q2 2024 in Review
Rafferty Asset Management sold out of bluebird bio (BLUE) in Q2 2024, closing a stake of 5,432 shares — an estimated $139K sold.
Rafferty Asset Management first reported a position in BLUE in Q1 2019 and held it in 21 quarters. The position peaked at $8.05M in Q4 2022. 150 funds tracked by Wall St. Rank hold BLUE as of Q2 2024.
- Rafferty Asset Management reported no remaining bluebird bio position as of Q2 2024 after selling out during the quarter.
- Rafferty Asset Management sold 5,432 bluebird bio shares in Q2 2024, an estimated $139K.
- Rafferty Asset Management first reported a position in bluebird bio in Q1 2019 and held it in 21 quarters.
- Rafferty Asset Management's bluebird bio position peaked at $8.05M in Q4 2022.
- 150 funds tracked by Wall St. Rank held bluebird bio as of Q2 2024.
Based on Rafferty Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.